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Abstract
Background: CUP-5 is a Transient Receptor Potential protein in C. elegans that is the orthologue of mammalian
TRPML1. Loss of TRPML1 results in the lysosomal storage disorder Mucolipidosis type IV. Loss of CUP-5 results in
embryonic lethality and the accumulation of enlarged yolk granules in developing intestinal cells. The embryonic
lethality of cup-5 mutants is rescued by mutations in mrp-4, which is required for gut granule differentiation. Gut
granules are intestine-specific lysosome-related organelles that accumulate birefringent material. This link between
CUP-5 and gut granules led us to determine the roles of CUP-5 in lysosome and gut granule biogenesis in
developing intestinal cells.
Results: We show that CUP-5 protein localizes to lysosomes, but not to gut granules, in developing intestinal cells.
Loss of CUP-5 results in defects in endo-lysosomal transport in developing intestinal cells of C. elegans embryos.
This ultimately leads to the appearance of enlarged terminal vacuoles that show defective lysosomal degradation
and that have lysosomal and endosomal markers. In contrast, gut granule biogenesis is normal in the absence of
CUP-5. Furthermore, loss of CUP-5 does not result in inappropriate fusion or mixing of content between lysosomes
and gut granules.
Conclusions: Using an in vivo model of MLIV, we show that there is a defect in lysosomal transport/biogenesis
that is earlier than the presumed function of TRPML1 in terminal lysosomes. Our results indicate that CUP-5 is
required for the biogenesis of lysosomes but not of gut granules. Thus, cellular phenotypes in Mucolipidosis type
IV are likely not due to defects in lysosome-related organelle biogenesis, but due to progressive defects in
lysosomal transport that lead to severe lysosomal dysfunction.
Background
Lysosomes are the major degradative organelles of endo-
cytosed, phagocytosed, and autophagocytosed material
[1,2]. Lysosomes also have specialized functions, for
example fusing with the plasma membrane to initiate
wound repair and mediating some cell death pathways
[3-5]. Lysosome biogenesis is a dynamic process, in
which late endosomes fuse with lysosomes resulting in a
hybrid late endosome/lysosomal organelle [6]. Late
endosomes and lysosomes are reformed from these
hybrid organelles, a process that requires the release of
intra-organellar Ca
2+ [6,7].
Some tissues have additional organelles called lyso-
some-related organelles (LROs) that are acidic, contain
some lysosomal proteins, and have cell type-specific
functions [8]. Although LROs derive from the endoso-
mal system, they are different from bona fide lysosomes
in composition, morphology, and function. Examples of
LROs include organelles with storage or secretion func-
tions, such as melanosomes in melanocytes, platelet-
dense granules in platelets, and acrosomes in sperm
cells [8-10]. In C. elegans embryos, gut granules are
LROs found in intestinal cells at all stages of develop-
ment [11-14]. These gut granules contain lipids, bire-
fringent material that is autofluorescent under several
wavelengths of light, and gut granule-specific proteins.
The function and biogenesis of gut granules is not com-
pletely understood.
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lysosomes in scavenger cells called coelomocytes [15,16].
CUP-5 is the sole orthologue of mammalian TRPML1
that is encoded by MCOLN1, mutations in which cause
Mucolipidosis type IV (MLIV) in humans [15,17]. Many
MLIV-associated defects that are linked to lysosomal
dysfunction have been described. Some examples
include an enlargement of lysosomes that accumulate
both lipid and water soluble material, a delay in the
transport of endocytosed lactosylceramide (LacCer)
from late endosomes/lysosomes to the Golgi Apparatus,
a delay in the degradation in and/or transport of endo-
cytosed lipids and proteins to lysosomes, and a delay in
the degradation of autophagosome material [18]. Similar
to the MLIV phenotypes, worms with a cup-5 mutation
have enlarged endo-lysosomal compartments in several
cell types, including developing intestinal cells and coe-
lomocytes [15,19]. Pulse-chase studies in coelomocytes
have shown that CUP-5 is required for the biogenesis of
lysosomes, the earliest MLIV-associated defect in the
endocytic pathway that has yet been described [16].
Loss of CUP-5 results in embryonic lethality [20]. In
these cup-5 mutant embryos, there is a significant enlar-
gement of yolk granules and a defect in the degradation
of endocytosed yolk proteins in developing intestinal
cells [20]. Loss of MRP-4 was shown to rescue both the
yolk granule/yolk degradation defects and the embryonic
lethality of cup-5 mutant [19]. However, MRP-4 is an
ATP-Binding Cassette (ABC) transporter that is required
for gut granule differentiation in developing intestinal
cells [21]. Because of the role of MRP-4 in LRO/gut gran-
ule differentiation and the mrp-4 mutant rescue of cup-5
mutants, we hypothesized that CUP-5 may play a role in
LRO biogenesis or differentiation, in addition to its role
in lysosome biogenesis. We therefore initiated this study
to decipher possible roles of CUP-5 in lysosome and gut
granule biogenesis in developing intestinal cells.
Results and discussion
Discrete late endocytic organelles and gut granules in the
developing intestine
Two late-stage endo-lysosomal organelles (yolk granules
and lysosomes) and one LRO (gut granules) have been
identified in developing intestinal cells of embryos
[11,22]. However, because there are no systematic stu-
dies that visualized all three organelles in developing
intestinal cells, it is not clear whether they indeed repre-
sent discrete and separate compartments. We therefore
first carried out colocalization studies in wild type
embryos to define these organelles using established
markers. We confined our analysis to specific stages of
embryonic development, “comma” to “1.5-fold”
stages, when the yolk granule defect is clearly observed
in cup-5 mutants [20].
Yolk granules in developing intestinal cells are late
endosomes that contain endocytosed yolk. During
oogenesis, yolk is first endocytosed by oocytes. During
early morphogenesis, yolk is secreted by all cells into
the perivitelline space and is subsequently endocytosed
by developing intestinal cells [23,24]. We visualized
these yolk granules using transgenic worms that express
a fusion of the yolk protein YP170 to GFP (YP170::GFP)
[25] (Fig. 1A-C; Additional file 1 Fig. S1B). Lysosomes
are terminal compartments that we visualize using
an LMP-1::GFP protein reporter (Kostich et al., 2000)
(Fig. 1D; Additional file 1 Fig. S1C). LMP-1 protein is
the C. elegans homologue of mammalian Lysosomal-
Associated Membrane Protein 1 (LAMP1) [22]. We also
made an LMP-1::TagRFP(S158T) protein reporter, repla-
cing GFP coding sequences with a red fluorescent pro-
tein (Fig. 1C). Gut granules are visualized using the
lipophilic dye Nile Red staining, UV autofluorescence
due to the presence of lipofuscin, or by PGP-2 protein
immuno-staining (Fig. 1A, B, D; Additional file 1 Fig.
S1) [11,12,19,26]. PGP-2 is an ABC transporter that
localizes to gut granules and is required for their bio-
genesis [26].
Yolk granules, lysosomes, and gut granules represent
distinct compartments of developing intestinal cells.
YP170::GFP did not colocalize with any of the gut gran-
ule markers at steady state (Fig. 1A, B; Additional file 1
Fig. S1B). This indicates that yolk granules are discrete
and separate from gut granules. Similarly, YP170::GFP
did not colocalize with LMP-1::TagRFP(S158T) at steady
state (Fig. 1C). This indicates that yolk granules and
lysosomes are distinct compartments; yolk is likely
transported to lysosomes but is degraded in these orga-
nelles. Finally, LMP-1::GFP did not colocalize with PGP-
2 or autofluorescence at steady state (Fig. 1D; Additional
file 1 Fig. S1C). This indicates that lysosomes and gut
granules are also discrete and separate organelles. Hav-
ing defined the identities of these organelles by light
microscopy studies, we then did localization and muta-
tional analyses to decipher roles of CUP-5 in organelle
biogenesis and transport in developing intestinal cells.
cup-5(zu223) lethality is primarily due to defects in the
developing intestine
W eh a dp r e v i o u s l ym a d eaf u n c t i o n a lG F P : : C U P - 5
fusion protein that rescued cup-5 mutant lysosomal
defects in C. elegans coelomocytes [16]. To assay
whether this GFP::CUP-5 also rescues intestinal defects
in embryos, we expressed this GFP::CUP-5 under the
control of an elt-2 promoter that drives expression in
developing intestinal cells [27]. Although most tissues of
cup-5(zu223) embryos show lysosomal defects, this Pelt-
2::gfp::cup-5 construct rescues the lethality in cup-5
(zu223) embryos: 5.4 ± 5.9% lethality compared with
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Page 2 of 10Figure 1 Late endocytic and lysosome-related organelles in developing intestinal cells of wild type embryos. A) Epifluorescence images
of a wild type embryo that expresses YP170::GFP and stained with Nile Red. B) Confocal images of a wild type embryo that expresses YP170::
GFP and immunostained to detect PGP-2. C) Epifluorescence images of a wild type embryo that expresses YP170::GFP and LMP-1::TagRFP(S158T).
D) Confocal images of a wild type embryo that expresses YP170::GFP and immunostained to detect PGP-2. Bottom panels are magnified images
of the regions indicated in the top panels. Scale bars in whole embryo images represent 10 μm; scale bars in magnified images represent 2 μm.
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Page 3 of 10Figure 2 CUP-5 protein localization in developing intestinal cells. A) Percent lethality of WT, cup-5(zu223), cup-5(zu223);P elt-2::gfp::cup-5 and
cup-5(zu223);P elt-2:: mCherry::cup-5 embryos. Error bars represent the 95% confidence intervals for significance. B) Epifluorescence images of a
wild type embryo that expresses LMP-1::GFP and mCherry::CUP-5. C) Confocal images of a wild type embryo that expresses GFP::CUP-5 and LMP-
1::TagRFP(S158T). D) Epifluorescence images of a wild type embryo that expresses YP170::GFP and mCherry::CUP-5. E) Confocal images of a wild
type embryo that expresses GFP::CUP-5 and immunostained to detect PGP-2. Bottom panels are magnified images of the regions indicated in
the top panels. Scale bars in whole embryo images represent 10 μm; scale bars in magnified images represent 2 μm.
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Page 4 of 10100% without the construct (Fig. 2A). This indicates that
the embryonic lethality of cup-5 mutant embryos is
mostly due to intestinal defects, which is consistent with
the strong suppression of cup-5 mutant lethality by loss
of MRP-4 since mrp-4 is only expressed in developing
intestinal cells [19,21]. Furthermore, elt-2 promoter
becomes active after the yolk granule defects manifest
themselves in cup-5 mutant embryos [20]. This suggests
that expression of CUP-5 is sufficient to reverse the
endocytic defects of the cup-5 mutant, an in vivo model
of MLIV.
W ea l s om a d eaP elt-2::mCherry::cup-5 expression
construct. This mCherry::CUP-5 fusion protein only
partially rescues cup-5(zu223) embryonic lethality
(Fig. 2A), indicating that mCherry interferes with CUP-5
activity. However, mCherry::CUP-5 and GFP::CUP-5
show 100% colocalization (data not shown). In addition,
GFP::CUP-5 and mCherry::CUP-5 show the same colo-
calization with LMP-1 in lysosomes (Fig. 2B, C). Thus
mCherry::CUP-5 is a useful marker for the subcellular
localization of CUP-5.
CUP-5 protein localizes to lysosomes
We had previously localized CUP-5 to lysosomes of coe-
lomocytes [16]. We wanted to determine whether
CUP-5 localizes only to lysosomes of developing intest-
inal cells or whether it is also found on yolk granules
and gut granules. We used our transgenic worms
expressing either GFP::CUP-5 or mCherry::CUP-5 in
intestinal cells for these localization studies.
mCherry::CUP-5 fully colocalizes with LMP-1::GFP
(Fig. 2B). We see similar colocalization between GFP::
CUP-5 and LMP-1::TagRFP(S158T) (Fig. 2C). Note that
in addition to lysosomes, LMP-1 also localizes to, or
close to, the plasma membrane of developing intestinal
cells. Consistent with the lysosomal localization of CUP-
5, there was no colocalization between mCherry::CUP-5
and YP170::GFP at steady state (Fig. 2D). We also did
not detect any colocalization between GFP::CUP-5 and
any gut granule markers (Fig. 2E; Additional file 2
Fig. S2).
Therefore, CUP-5 protein localizes to lysosomes at
steady state in developing intestinal cells. We next
assayed whether loss of CUP-5 causes content mixing
between yolk granules, lysosomes, and gut granules.
Yolk Granule and lysosome content mixing in the cup-5
(zu223) mutant
To determine whether CUP-5 affects yolk granule, lyso-
some, and gut granule biogenesis, we did localization
studies between markers for yolk granules, lysosomes,
and gut granules in cup-5(zu223) embryos. Similar to
wild type embryos, YP170::GFP did not colocalize with
any of the gut granule markers at steady state in cup-5
(zu223) embryos (Fig. 3A, B; Additional file 3 Fig. S3A).
This indicates that yolk granules remain discrete and
separate from gut granules in the absence of CUP-5. In
contrast to wild type embryos, LMP-1::TagRFP(S158T)
localized to the limiting membranes of compartments
that contained YP170::GFP in mutant embryos (Fig. 3C).
Specifically, we found that all compartments that were
labeled with LMP-1::TagRFP(S158T) also contained
YP170::GFP (arrowheads in Fig. 3C), but some YP170::
GFP-containing compartments did not show detectable
LMP-1::TagRFP(S158T) (arrows in Fig. 3C, Additional
file 4 Fig. S4). This indicates that there is a transport
defect between yolk granules and lysosomes in the
absence of CUP-5. Consistent with these results, LMP-
1::GFP did not colocalize with the gut granule marker
PGP-2 or gut granule lipofuscin (Fig. 3D; Additional
file 3 Fig. S3B). Thus in the absence of CUP-5, there is
an apparent mixing of content of lysosomes and of yolk
granules, while the gut granules remain discrete and
separate compartments. This indicates that gut granule
biogenesis is normal in the absence of CUP-5. We
therefore asked whether there is a defect in the
morphologies or content of the various organelles.
Alteration in size and content of yolk granules/lysosomes
in the cup-5(zu223) mutant
We had previously shown an enlargement of the total
population of yolk granules and an accumulation of
YP170::GFP in C. elegans cup-5(zu223) mutants [20].
We visualized markers for the different organelles in
wild type and cup-5(zu223) embryos using identical
microscopy parameters that allow us to compare sizes
of organelles and intensities of staining of each marker.
To determine the sizes of the compartments, we relied
on endogenous markers, YP170::GFP for yolk granules,
LMP-1::GFP for lysosomes, and autofluorescence for gut
granules; this eliminates potential variability due to exo-
genous staining with dyes. Indeed, Nile Red staining of
gut granules showed significant variability in staining
quality between different experiments. We also used
PGP-2 antibody immunostaining to confirm sizes of gut
granules.
We first confirmed the yolk protein processing defects
(Fig. 4A). Because some YP170::GFP-containing com-
partments contained LMP-1::TagRFP(S158T) and some
did not in the cup-5(zu223) mutant, we measured the
size and signals of both populations of YP170::GFP com-
partments. These two YP170::GFP-containing popula-
tions differed in size and intensity in the cup-5(zu223)
mutant: compartments that contained only YP170::GFP
were significantly smaller than those with both YP170::
GFP and LMP-1::TagRFP(S158T) (1.54 ± 0.38 μm
2 com-
pared with 2.93 ± 0.61 μm
2,p - v a l u e=2 . 4 4×1 0
-4)
(Fig. 4A). The intensity per unit area of GFP in YP170::
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Page 5 of 10Figure 3 Late endocytic and lysosome-related organelles in developing intestinal cells of cup-5 mutant embryos. A) Confocal images of
a cup-5(zu223) embryo that expresses YP170::GFP and stained with Nile Red. B) Confocal images of a cup-5(zu223) embryo that expresses YP170::
GFP and immunostained to detect PGP-2. C) Epifluorescence images of a cup-5(zu223) embryo that expresses YP170::GFP and LMP-1::TagRFP
(S158T). Small arrows point to organelles containing only YP170::GFP; large arrowheads point to organelles containing both YP170::GFP and LMP-
1::TagRFP(S158T). D) Confocal images of a cup-5(zu223) embryo that expresses LMP-1::GFP and immunostained to detect PGP-2. Bottom panels
are magnified images of the regions indicated in the top panels. Scale bars in whole embryo images represent 10 μm; scale bars in magnified
images represent 2 μm.
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Page 6 of 10GFP-only compartments was also lower than compart-
ments with YP170::GFP and LMP-1::TagRFP(S158T) in
the cup-5 mutant (p-value = 2.76 × 10
-3) (Fig. 4A).
We next compared these two populations of YP70::
GFP compartments in the cup-5 mutant to yolk gran-
ules in wild type. The YP170::GFP-only compartments
in the cup-5(zu223) mutant were larger than YP170::
GFP compartments in wild type (1.54 ± 0.38 μm
2 com-
pared with 0.92 ± 0.05 μm
2,p - v a l u e=1 . 9 2×1 0
-7),
although the intensities of GFP were similar in both
cases (p-value = 0.14) (Fig. 4A). The compartments
that contained both YP170::GFP and LMP-1::TagRFP
(S158T) in the cup-5(zu223) mutant were much larger
than YP170::GFP yolk granules in wild type (2.93 ±
0.61 μm
2 compared with 0.92 ± 0.05 μm
2,p - v a l u e=
1.80 × 10
-22), and had a higher intensity of GFP than
wild type (p-value = 2.10 × 10
-9)( F i g .4 A ) .T h u si nt h e
a b s e n c eo fC U P - 5 ,t h e r ei sad e f e c ti ny o l kg r a n u l e s /
late endosomes prior to the lysosomal expansion
described in MLIV cells: yolk granules/late endosomes
progressively increase in size before they start accumu-
lating lysosomal markers and showing defects in
degradation.
Consistent with the colocalization of LMP-1 and
YP170 in the absence of CUP-5, LMP-1::GFP puncta
were also larger in cup-5(zu223) than in wild type (1.37
±0 . 4 0μm
2 compared with 0.71 ± 0.05 μm
2,p - v a l u e=
6.19 × 10
-4) (Fig. 4B). Furthermore, the intensity of
LMP-1::GFP was also higher in cup-5(zu223) developing
intestinal cells, indicating a defect in the turnover of
LMP-1 (p-value = 5.02 × 10
-7) (Fig. 4B).
In contrast to the yolk granule/lysosome defect, there
was no apparent effect of the loss of CUP-5 on gut
granule size. Gut granule sizes were similar in cup-5
(zu223) and in wild type embryos based on UV fluores-
cence (1.17 ± 0.07 μm
2 for mutant, 1.11 ± 0.06 μm
2 for
wild type, p-value = 0.25) and PGP-2 immunofluores-
cence (0.70 ± 0.04 μm
2 for mutant, 0.76 ± 0.04 μm
2 for
wild type, p-value = 0.06) (Fig. 4C, D). However, the
intensity per unit area of autofluorescent material was
statistically lower per unit area in cup-5(u223) mutant
embryos compared with wild type embryos (p-value =
2.3 × 10
-16) (Fig. 4D), while the intensity per unit area
of PGP-2 immunofluorescence was similar in both wild
type and mutant embryos (p-value = 0.57) (Fig. 4C).
Thus while the biogenesis of gut granules is normal, the
Figure 4 cup-5 mutant effects on sizes and intensities of markers of late endocytic and lysosome-related organelles in developing
intestinal cells. Images of wild type and cup-5(zu223) embryos, as well as quantification of sizes and intensities per unit area of compartments
with YP170::GFP (A), LMP-1::GFP (B), PGP-2 (C), and UV (D) signals. Images for the same marker were taken using the same microscopy
parameters. Scale bars represent 10 μm. Error bars represent the 95% confidence intervals for significance, and asterisks represent statistical
significance at p < 0.05, compared to WT. In cup-5(zu223) embryos, the difference in areas of YP170::GFP organelles (A) with or without LMP-1::
TagRFP(S158T) is also statistically significant.
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Page 7 of 10loss of CUP-5 may have indirect effects on the composi-
tion of these granules; the severe yolk granule/lysosome
defect in the cup-5 mutant may affect the trafficking of
some gut granule proteins.
Conclusion
The localization of CUP-5 primarily to lysosomes and the
cup-5 mutant defects are both consistent with a model
where CUP-5 functions primarily in lysosome biogenesis
and/or transport but does not function in the biogenesis
of gut granules. We propose that YP170 is transported
from early endosomes to late endosomes (yolk granules)
in both wild type and cup-5 mutant embryos (Fig. 5). In
w i l dt y p e ,Y P 1 7 0 ,L M P - 1 ,a n dC U P - 5a r ee f f i c i e n t l y
transported to lysosomes where YP170 is degraded. In
the absence of CUP-5, the rate of YP170 and LMP-1
transport to lysosomes is reduced leading to the progres-
sive enlargement of yolk granules (Fig. 5). Eventually, this
results in a terminal phenotype, the appearance of large
vacuoles that accumulate both YP170 and LMP-1. Gut
granules/LROs are presumed to originate from early
endosomes. The observation that loss of CUP-5 has a
minimal effect on the formation of gut granules indicate
that CUP-5 functions downstream of this early endo-
somal sorting step but upstream of late endosome-to-
lysosome transport. However, as this yolk granule/lysoso-
mal defect gets more severe in the absence of CUP-5, it
indirectly impacts the trafficking of some gut granule
proteins. Our results suggest that MLIV patients will
show normal LROs that would not contribute to the
symptoms of the disease. Furthermore, our in vivo stu-
dies suggest that TRPML1 has functions in late endo-
some-to-lysosome transport that are earlier than those
inferred from some of the terminal lysosomal defects
described in cell culture models of MLIV; these terminal
lysosomal defects include defective lysosome/autophago-
some fusion and reformation and lysosome exocytosis
[28-32].
Methods
C. elegans strains
The following strains were used in this study: GS2886:
unc-36(e251); bIs1(vit-2::gfp; pRF4); RT258: unc-119
(ed3); pwIs50(lmp-1::gfp, unc-119(+);N P 9 5 2 :cup-5
(zu223) unc-36(e251)/qC1; bIs1(vit-2::gfp; pRF4)[16,20].
We created, using bombardment methods, strains with
the following transgenes [33]: cdIs184(Pelt-2::GFP:CUP-
5; punc-119(+)-myo-2::GFP); cdIs190(Pelt-2::mCherry:
CUP-5; punc-119(+)-myo-2::GFP); cdIs194(lmp-1::
TagRFP(S158T); unc-119(+)-ttx-3::gfp). TagRFP(S158T)
is a bright monomeric red fluorescent protein [34].
Plasmid construction
The LMP-1::TagRFP(S158T) plasmid was made
by replacing the GFP with TagRFP(S158T) coding
sequences in a plasmid that expresses an LMP-1::GFP
fusion protein [16]. The ~742 bp TagRFP(S158T) cDNA
was PCR amplified (primers CACACAACCGGTA-
GAAAAAATGGTGTCTAAGGGCGAAGAGC and
CACACAGAATTCCAAAGCTTGTGGGCTTTTAT-
TAAGTTTGTGCCCCAGTTTG), restriction digested
with AgeI+EcoRI and ligated into the 2979 bp fragment
of pHD43 to make plasmid pHD491[35]. The 3532 bp
SphI+AgeIf r a g m e n to fp H D 4 9 1w a st h e nl i g a t e dt o
the 3946 bp SphI+AgeI fragment of pPD117.01-LMP-1
to make plasmid pHD499 used to make transgenic lines.
The GFP::CUP-5 and mCherry::CUP-5 plasmids were
made by inserting the elt-2 promoter to existing GFP::
CUP-5 and mCherry::CUP-5 plasmids (pJF168 and
pHD260, respectively). The elt-2 promoter was PCR
Figure 5 Model of CUP-5 functions in developing intestinal cells. Drawings of intestinal cells showing the markers used in this study in wild
type and cup-5 mutant embryos. Organelles are not drawn to actual scale.
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Page 8 of 10amplified (primers CACACACCGGGCTGCAGGAATT
CACATA and CACACACGCGGATCCATTCTATAAT)
from pJM260, and restriction digested with PstIa n d
BstUI. Both GFP::CUP-5 and mCherry::CUP-5, pJF168
and pHD260, respectively, were restriction digested with
BmtI, incubated with T4 DNA Polymerase to create a
blunt end, and then digested with PstI. The promoter
fragment (5057 bp) was then ligated to the pJF168 frag-
ment (6074 bp) and pHD260 fragment (6227 bp) to
make pHD423 and pHD429, used to make transgenic
lines.
Microscopy
Nile Red is a lipophilic membrane-permeable dye that
diffuses across membranes and fluoresces when it com-
plexes with lipids [24,26,36]. For Nile Red staining, adult
worms were placed on OP50 bacteria suspended in 60
ug/ml Nile Red, on NGM plates with 60 ng/ml Nile Red
(Invitrogen, Carlsbad, CA). Worms were allowed to lay
embryos overnight, and embryos were immediately
imaged. For imaging of live worm embryos (Nile Red,
UV imaging, and fluorescently tagged constructs),
embryos were resuspended in M9 buffer and dropped
onto 3% agar pads; coverslips were added and sealed
with petroleum jelly.
For PGP-2 immunostaining, embryos were dropped
onto slides coated with poly-l-lysine (Sigma, St. Louis,
MO) and covered with a coverslip. Slides were quickly
frozen on a metal plate cooled over dry ice, and cover-
slips were flicked off the slides. Slides then underwent
one 15-minute 100% methanol wash at -20°. Slides were
washed twice with PBST (PBS plus 0.1% Tween), and
blocked with PBS, 1% nonfat milk, 1% BSA, 0.1% Tween
for 2 hours at 4°. Anti-PGP-2 antibody was added at
1:500 dilution in the above blocking buffer and left over-
night at 4°, followed by three 10-minute washes in PBST
[26]. Secondary anti-rabbit Cy3 antibody (Jackson
ImmunoResearch Laboratories, West Grove, PA) was
added at 1:200 dilution in blocking buffer for two hours
at room temperature, followed by three 10-minute
washes in PBST. Excessive moisture was wicked away
from embryos, and mounting media (Invitrogen) was
added prior to imaging.
Confocal images were taken on a Zeiss LSM510 (Carl
Zeiss, Oberkochen, Germany) laser scanning confocal,
using LSM imaging software. Epifluorescence images
were taken on a Leica DMRXA compound microscope
(Leica Microsystems, Wetzlar, Germany), using Meta-
Morph software (Molecular Devices, Sunnyvale, CA).
For colocalization analysis and quantification of orga-
nelle size and intensity, MetaMorph (Molecular Devices)
was used, and Microsoft Excel was used for statistical
analysis. For each embryo measured, two 7 × 7 μm
boxes were drawn, and all compartments within each
box were measured for area and intensity per unit area.
For YP170::GFP and LMP-1::GFP experiments, one
z-section for each of five embryos of each genotype was
measured. For PGP-2 and UV experiments one z-section
of five embryos of each genotype was measured. We
used two-tailed t-test p-values to determine significance
in all experiments. Figs. 1, 2, 3 and 4 and Additional
files were assembled using Adobe Photoshop (Adobe
Systems Incorporated, San Jose, CA), and Fig. 5 was
assembled using Canvas (ACD Systems, Victoria, BC
Canada).
Additional file 1: Fig. S1 - Late endocytic and lysosome-related
organelles in developing intestinal cells of wild type embryos.
Supplementary figure showing images of wild type embryos stained to
detect various compartments in developing intestinal cells.
Additional file 2: Fig. S2 - CUP-5 protein localization in developing
intestinal cells. Supplementary figure showing images of wild type
embryos expressing GFP::CUP-5 and stained to detect gut granules in
developing intestinal cells.
Additional file 3: Fig. S3 - Late endocytic and lysosome-related
organelles in developing intestinal cells of cup-5 mutant embryos.
Supplementary figure showing images of cup-5 mutant embryos stained
to detect various compartments in developing intestinal cells.
Additional file 4: Fig. S4 - Late endocytic organelles in developing
intestinal cells of cup-5 mutant embryos. Supplementary figure
showing images of cup-5 mutant embryos stained to detect YP170::GFP
and LMP-1::RFP in developing intestinal cells.
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